Eli Lilly outlays $7.3bn to acquire sleep drug biotech Centessa [Yahoo! Finance]
Jazz Pharmaceuticals plc - Ordinary Shares (JAZZ)
Last jazz pharmaceuticals plc - ordinary shares earnings: 2/25 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
jazzpharma.com
Company Research
Source: Yahoo! Finance
the drugmaker's status as one of the most dominant players in the pharma deals arena so far this year. As per the takeover deal, Lilly will acquire UK-based Centessa for $38 a share, representing a 37% premium on the Nasdaq closing price of $27.58 on 30 March. Despite the front-loaded nature of the deal, Centessa could also receive an additional $9 per share in contingent value rights (CVR). Whether that extra $1.5bn in CVR is added to the deal hinges on three milestones for cleminorexton, Centessa's lead candidate. The asset, formerly known as ORX750, has already demonstrated positive results in Phase II studies across a range of sleep-wake cycle conditions, including narcolepsy type 1, narcolepsy type 2, and idiopathic hypersomnia. In a research note following the deal, Citi analysts commented: “We think this could be an impactful expansion of Lilly's neuroscience portfolio, given the large collective total addressable market across the three indications.” The Lilly acquisit
Show less
Read more
Impact Snapshot
Event Time:
JAZZ
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
JAZZ alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
JAZZ alerts
High impacting Jazz Pharmaceuticals plc - Ordinary Shares news events
Weekly update
A roundup of the hottest topics
JAZZ
News
- Jazz Pharmaceuticals to Participate in Needham Virtual Healthcare Conference [Yahoo! Finance]Yahoo! Finance
- Jazz Pharmaceuticals to Participate in Needham Virtual Healthcare ConferencePR Newswire
- Jazz Pharmaceuticals to Participate in Needham Virtual Healthcare ConferencePR Newswire
- Investors Have Been Waiting to Buy the Dip in This Hot Biopharma Stock [Yahoo! Finance]Yahoo! Finance
- Why Is Jazz (JAZZ) Down 3.9% Since Last Earnings Report? [Yahoo! Finance]Yahoo! Finance
JAZZ
Earnings
- 2/24/26 - Beat
JAZZ
Sec Filings
- 4/1/26 - Form 144
- 3/27/26 - Form SCHEDULE
- 3/9/26 - Form 4
- JAZZ's page on the SEC website